Advances in the percutaneous treatment of aortic and mitral valve disease

V Rajagopal1, S R Kapadia, E M Tuzcu

  • 1Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.

Minerva Cardioangiologica
|February 9, 2007
PubMed

Insights

As the population ages, valvular heart disease (VHD) burden grows. Catheter-based treatments show promise for VHD, expanding options beyond traditional surgery.

Area of Science:

  • Cardiology
  • Medical Technology

Background:

  • Valvular heart disease (VHD) poses a growing healthcare challenge, particularly in aging populations.
  • Surgical valve repair and replacement are the established standard of care due to excellent safety and durability.
  • Patient comorbidities often increase surgical risks, driving demand for less invasive alternatives.

Purpose of the Study:

  • To review the emerging role of catheter-based interventions for valvular heart disease.
  • To highlight advancements in percutaneous valve repair and replacement technologies.

Main Methods:

  • Review of current literature and early human studies on catheter-based valve interventions.
  • Analysis of technological advancements in percutaneous aortic and mitral valve procedures.

Main Results:

  • Early human trials of aortic stent-valve prostheses demonstrate encouraging outcomes.
  • Percutaneous mitral valve repair techniques, including annuloplasty and leaflet repair, show feasibility in initial studies.
  • Technological progress and accumulating experience are expanding the potential of percutaneous treatments for VHD.

Conclusions:

  • Catheter-based valve repair and replacement are evolving as viable alternatives for VHD treatment.
  • Ongoing clinical trials are crucial for establishing long-term safety, durability, and optimal patient selection for percutaneous VHD therapies.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...